We are live on
!
Find out more
Oragenics
OGEN
OGEN
11 hedge funds and large institutions have $2.29M invested in Oragenics in 2018 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
0% more funds holding
Funds holding: 11 → 11 (0)
0% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 3
0.01% less ownership
Funds ownership: 0.02% → 0.01% (-0.01%)
16% less capital invested
Capital invested by funds: $2.73M → $2.29M (-$438K)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
Holders
11
Holders Change
–
Holders Change %
0%
% of All Funds
0.25%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
1
Reduced
2
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
WC
Wexford Capital
West Palm Beach,
Florida
|
+$384K |
| 2 |
Barclays
London,
United Kingdom
|
+$34.6K |
| 3 |
TSS
Two Sigma Securities
New York
|
+$32.3K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$19.6K |
Top Sellers
| 1 |
Morgan Stanley
New York
|
-$107K |
| 2 |
VF
Virtu Financial
New York
|
-$16.1K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$7K |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$6.92K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$2K |